Gestational diabetes mellitus (GDM) is a form of high blood sugar that develops during pregnancy in someone who did not have diabetes before conceiving. It typically appears in the second or third trimester, driven by hormonal shifts that make the body less responsive to insulin. What makes GDM unusual compared with most health conditions is that it rarely announces itself with noticeable symptoms, so screening is the only reliable way to catch it. The condition affects a significant and growing share of pregnancies worldwide, and while it usually resolves after delivery, its ripple effects on both parent and child can persist for decades.
Why Pregnancy Itself Creates the Problem
Every pregnancy triggers a deliberate metabolic shift. The placenta releases hormones that partially block insulin’s ability to shuttle glucose out of the bloodstream and into cells. This is not a malfunction. From an evolutionary standpoint, the fetus benefits from having more glucose available in the mother’s blood after meals, because glucose crosses the placenta easily and fuels fetal growth. One key hormone, human placental lactogen, acts on the mother’s cells to increase insulin resistance. Normally the mother’s pancreas compensates by producing more insulin. Gestational diabetes develops when that compensation falls short.
1PubMed. Genetic conflicts in human pregnancyThe placenta also produces inflammatory signals that further reduce insulin sensitivity. A review of the molecular mechanisms involved describes this interplay as a cascade of hormonal and pro-inflammatory changes that, when they overwhelm the mother’s capacity to respond, push blood sugar above normal thresholds.
2Europe PMC. The Placental Role in Gestational Diabetes Mellitus: A Molecular PerspectiveThere is also emerging interest in the gut microbiome’s role. Pregnancy alters the composition of intestinal bacteria in ways that promote inflammation and insulin resistance, mirroring some of the same microbial patterns seen in type 2 diabetes outside of pregnancy.
3PubMed Central. Gut Microbiome Changes in Gestational DiabetesThe Symptom Problem
If you are expecting a list of telltale signs to watch for, here is the uncomfortable truth: GDM usually produces no symptoms the person can feel. Ethnographic research in hospital settings has described how the condition “is enacted not through embodied symptoms but through numerical thresholds, creating a clinical reality that arrives unannounced and often departs before it is ever felt.”4PubMed. Brief Illness, Haunting Effects: Gestational Diabetes and the Spectrality of Care In other words, you find out you have GDM because a lab test says so, not because something feels wrong.
Some people with markedly elevated blood sugar may notice increased thirst, more frequent urination, or fatigue. But those sensations overlap so heavily with normal pregnancy discomforts that they are essentially useless as diagnostic clues. This is precisely why routine screening between weeks 24 and 28 is standard practice in most countries.
Who Is at Higher Risk
Certain factors make GDM more likely, and some of them are not modifiable. Ethnicity is one of the strongest independent predictors. In a large California-based study, GDM prevalence ranged from about 4% among non-Hispanic white women up to roughly 11% among Asian Indian women, with Filipina and Southeast Asian women also at elevated risk.
5PubMed Central. Disparities in the risk of gestational diabetes by race-ethnicity and country of birthA separate analysis found GDM prevalence as high as about 19% among Asian Indian women when studied using WHO diagnostic criteria, and confirmed that the relative importance of individual risk factors varies by ethnic group. Overweight and obesity were the single most important risk factor for non-Hispanic white, Hispanic, Asian Indian, and Filipina women, while family history of diabetes and being born outside the United States carried outsized weight in several Asian subgroups.
6PubMed Central. Racial/Ethnic Differences in Gestational Diabetes Prevalence and Contribution of Common Risk FactorsOlder maternal age is also a consistent risk factor across ethnic groups, though its impact appears stronger in non-Hispanic white and Hispanic women than in others.7PubMed. High prevalence of gestational diabetes in women from ethnic minority groups Other well-established risk factors include a personal history of GDM in a prior pregnancy, a family history of type 2 diabetes, previous delivery of a baby weighing more than about nine pounds, and polycystic ovary syndrome.
How GDM Is Diagnosed
There are two main screening approaches used around the world, and which one your provider follows matters more than most people realize. The two-step method, favored in the United States, starts with a one-hour glucose challenge test. If you fail that initial screen, you go back for a longer three-hour oral glucose tolerance test. The one-step method, recommended by the International Association of Diabetes and Pregnancy Study Groups, skips the initial screen and goes straight to a two-hour glucose tolerance test with lower diagnostic thresholds.
The practical difference is significant. A meta-analysis of randomized trials found that women screened with the one-step method were roughly twice as likely to be diagnosed with GDM compared with those screened using two steps, with pooled diagnosis rates of about 16% versus 8%.8PubMed Central. One- Compared to Two-Step Gestational Diabetes Screening and Pregnancy Outcomes: A Systematic Review and Meta-analysis That does not necessarily mean the one-step method over-diagnoses. It catches milder cases that the two-step method misses. But meta-analysis data showed no significant difference in the rate of large-for-gestational-age babies between the two approaches, while the one-step group saw slightly higher rates of neonatal intensive care admissions and neonatal low blood sugar.9American Journal of Obstetrics & Gynecology MFM. One-step vs 2-step gestational diabetes mellitus screening methods and pregnancy outcomes The debate over which method produces better overall outcomes remains unresolved.
There is also growing interest in identifying GDM risk earlier in pregnancy. A scoping review of first-trimester biomarkers found that certain markers, including the pregnancy-associated protein PAPP-A, show promise for flagging women at risk months before conventional screening would catch the condition.10PubMed Central. First-trimester biomarkers of gestational diabetes mellitus: A scoping review None of these early biomarkers have been incorporated into routine clinical guidelines yet.
Risks to the Baby During Pregnancy and Delivery
When a mother’s blood sugar stays elevated, extra glucose crosses the placenta and reaches the fetus. The fetal pancreas responds by producing more insulin, and insulin acts as a growth hormone. The result is a condition called macrosomia, where the baby grows larger than expected. This excess growth is driven by the combination of surplus nutrients and the fetus’s own insulin overproduction.11PubMed Central. Consequences of gestational and pregestational diabetes on placental function and birth weight
A large baby creates practical complications during delivery, including increased risk of shoulder dystocia (where the baby’s shoulder gets stuck behind the pubic bone), birth injuries, and the need for cesarean delivery. After birth, the baby’s insulin levels may still be elevated even though the glucose supply from the mother has been cut off, which can cause dangerously low blood sugar in the first hours of life. GDM has also been linked to respiratory distress syndrome in newborns.12Journal of Health. Gestational Diabetes Mellitus and Birth Weight with Respiratory Distress Syndrome (RDS) in Neonates
Risks to the Mother
The most commonly discussed maternal complication is an increased rate of cesarean delivery. Among women with GDM, the odds of cesarean delivery climb substantially when obesity, first pregnancy, or a history of prior cesarean section are also present.13PubMed Central. Predictors of cesarean delivery in pregnant women with gestational diabetes mellitus
GDM also raises the risk of preeclampsia, a serious pregnancy complication involving high blood pressure and organ damage. Research shows that GDM is independently associated with preeclampsia in singleton pregnancies, and when the two conditions co-occur, the risks of preterm birth, cesarean delivery, and fetal growth restriction all increase further.14PubMed Central. Gestational Diabetes Mellitus and Preeclampsia: Correlation and Influencing Factors15Clinical and Experimental Obstetrics & Gynecology. Effect of Combined Gestational Diabetes Mellitus and Preeclampsia on Pregnancy Outcomes
The longer-term risk that gets less attention is the progression to type 2 diabetes. A large retrospective cohort study found that the cumulative risk of developing type 2 diabetes after a GDM pregnancy was about 26% at 15 years.16PubMed. Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis Another study following women over an even longer period reported that the heightened risk persists for more than 35 years, though it does decline with time. Women who had GDM in more than one pregnancy faced an even steeper trajectory.17PubMed Central. Persistence of Risk for Type 2 Diabetes After Gestational Diabetes Mellitus
Diet and Exercise as First-Line Treatment
For most women diagnosed with GDM, the first line of management is dietary change and physical activity. The goal is to keep blood sugar within target ranges: generally under 95 mg/dL fasting and under 140 mg/dL one hour after meals or under 120 mg/dL two hours after meals.18Diabetes Care. Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes Mellitus: A Randomized Controlled Trial
Choosing lower-glycemic-index foods makes a measurable difference. In a randomized trial, only about 29% of women assigned to a low-glycemic-index diet eventually needed insulin, compared with 59% on a conventional higher-glycemic-index diet. The researchers concluded that the dietary approach effectively halved the need for insulin without compromising outcomes for mother or baby.19PubMed Central. Can a low-glycemic index diet reduce the need for insulin in gestational diabetes mellitus? A randomized trial
Exercise is equally valuable. International guidelines consistently recommend aerobic activity ranging from about 60 to 150 minutes per week, with most capping individual sessions at 30 minutes. Exercise is considered safe even on a daily basis, and several national guidelines also recommend resistance training.20PubMed. Guidelines for exercise during normal pregnancy and gestational diabetes: a review of international recommendations A randomized controlled trial of combined aerobic and resistance exercise in women with GDM found that the exercise group had significantly lower post-meal blood sugar by late pregnancy.21PubMed. Combination of a structured aerobic and resistance exercise improves glycaemic control in pregnant women diagnosed with gestational diabetes mellitus. A randomised controlled trial
When Medication Becomes Necessary
When diet and exercise alone do not keep blood sugar within target, medication enters the picture. Insulin has traditionally been the default because it does not cross the placenta. Metformin and glyburide (also called glibenclamide) are oral alternatives that are increasingly used, though both can cross the placenta to some degree, which has kept the debate over their safety alive.
Meta-analyses comparing these options have found some surprising patterns. When metformin was compared with insulin, insulin was associated with higher rates of preeclampsia, neonatal low blood sugar, neonatal intensive care admissions, and macrosomia.22PubMed Central. Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis A separate meta-analysis of 26 randomized controlled trials confirmed many of these findings and additionally reported higher rates of maternal low blood sugar, neonatal jaundice, and neonatal intensive care admissions with insulin compared with metformin, though insulin was linked to lower rates of birth injury.23PubMed. Comparison of the effectiveness and safety of insulin and oral hypoglycemic drugs in the treatment of gestational diabetes mellitus: a meta-analysis of 26 randomized controlled trials
Glyburide generally fared less well in these comparisons, with higher neonatal low blood sugar rates than either insulin or metformin. The current consensus in the research community leans toward metformin as a reasonable alternative to insulin for many women, while acknowledging that more data on long-term outcomes for children exposed to metformin in utero would be reassuring.
Blood Sugar Monitoring Technology
Traditional GDM management relies on finger-prick blood glucose checks several times a day. Continuous glucose monitors (CGMs), small sensors worn on the skin that measure glucose every few minutes, are increasingly being explored as an alternative. A review of the technology concluded that CGM can safely monitor blood glucose in pregnant women and reduce both the swings in blood sugar and the occurrence of serious high or low episodes.24PubMed Central. Progress and indication for use of continuous glucose monitoring in patients with diabetes in pregnancy: a review
The appeal is intuitive: CGM gives you a continuous picture rather than isolated snapshots, and it can reveal post-meal spikes you would otherwise miss between finger pricks. However, the field has not yet agreed on specific CGM-derived targets for women with GDM. Metrics like time in range, time above range, and glucose variability show promise, but standardized thresholds that clinicians can use to guide treatment decisions are still under development.25PubMed. Continuous Glucose Monitoring in Gestational Diabetes Mellitus: Evidence, Clinical Benefits and Remaining Challenges
What Happens to the Children Long-Term
GDM’s influence does not end at delivery. Children born to mothers with GDM face a higher risk of becoming overweight or obese in early childhood. A cross-sectional study of children aged two to five found that mothers who had GDM were about twice as likely to have an overweight or obese child at that age, even after controlling for other factors.26PubMed Central. Maternal Gestational Diabetes Is Associated with High Risk of Childhood Overweight and Obesity: A Cross-Sectional Study in Pre-School Children Aged 2–5 Years
The proposed mechanism ties back to what happened in the womb. Fetal exposure to elevated glucose and the resulting surge in fetal insulin may permanently alter how the child’s body handles fat storage, glucose tolerance, and insulin sensitivity.27PubMed Central. Gestational diabetes and childhood obesity: what is the link? Research tracking children through adolescence has shown that the development of metabolic syndrome in these offspring increases with age and is related to maternal GDM, third-trimester blood sugar levels, maternal obesity, neonatal macrosomia, and childhood obesity itself, creating a chain of risk factors that compound over time.28PubMed. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome?
The Mental Health Dimension
A GDM diagnosis can carry a psychological weight that goes underappreciated. A systematic review and meta-analysis found that women with GDM had roughly twice the odds of depressive symptoms around the time of diagnosis and about 60% higher odds of postnatal depression compared with women without the condition.29PubMed Central. Is there an increased risk of perinatal mental disorder in women with gestational diabetes? A systematic review and meta-analysis A separate review reported that women with GDM scored higher on measures of anxiety, depression, stress, and physical symptom distress than healthy pregnant controls.30PubMed Central. Assessing Mental Health Conditions in Women with Gestational Diabetes Compared to Healthy Pregnant Women
Not every study agrees. Some large population-based analyses have found no independent association between GDM and new-onset mental illness. But after weighing the conflicting evidence, a systematic review concluded that GDM does appear to increase susceptibility to both anxiety and depression during pregnancy and after delivery.31PubMed Central. Associations between Gestational Diabetes and Anxiety or Depression: A Systematic Review The daily burden of monitoring, dietary restriction, and medical appointments likely contributes, on top of whatever biological mechanisms may be at work. If you have been diagnosed with GDM and notice persistent low mood, anxiety, or a sense of being overwhelmed, flagging it for your care team is worthwhile.
Postpartum Follow-Up and Why It Matters
GDM typically resolves within days of delivery, once the placenta is no longer producing the hormones that drove insulin resistance. But the story does not end there. Guidelines recommend a glucose tolerance test at six to twelve weeks postpartum to check whether blood sugar has truly normalized. Unfortunately, a substantial number of women never complete this screening. Studies have found postpartum glucose testing rates ranging from about 34% to 73%, with younger women, lower-income women, and certain racial and ethnic minority groups being less likely to follow through.32PubMed Central. Postpartum Screening for Diabetes Among Women With a History of Gestational Diabetes Mellitus Among those who were screened, a moderate proportion had already developed prediabetes (roughly 12% to 36%) or overt type 2 diabetes (about 1% to 5%).
Targeted awareness campaigns can improve these rates. One multicentre initiative raised the postpartum screening rate from about 33% to 49%. Women who had required insulin during pregnancy and those with healthier lifestyle habits were more likely to complete screening.33PubMed. Improving postpartum glucose screening after gestational diabetes mellitus: a cohort study to evaluate the multicentre IMPACT initiative
Breastfeeding appears to offer a meaningful protective effect. Research has shown that mothers with GDM who breastfeed have improved blood sugar and lipid profiles in the first three months after birth. One long-term prospective study found that breastfeeding for three months or longer reduced the risk of developing type 2 diabetes and delayed its onset by about ten years compared with breastfeeding for shorter periods.34PubMed Central. Beneficial effects of breastfeeding in women with gestational diabetes mellitus Given the decades-long shadow that GDM casts over type 2 diabetes risk, these postpartum interventions, though modest individually, add up.